DK0570682T3 - Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner - Google Patents

Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner

Info

Publication number
DK0570682T3
DK0570682T3 DK93104369.9T DK93104369T DK0570682T3 DK 0570682 T3 DK0570682 T3 DK 0570682T3 DK 93104369 T DK93104369 T DK 93104369T DK 0570682 T3 DK0570682 T3 DK 0570682T3
Authority
DK
Denmark
Prior art keywords
vaccines
synthetic lipid
glycoconjugate antigens
antigens
glycoconjugate
Prior art date
Application number
DK93104369.9T
Other languages
Danish (da)
English (en)
Inventor
Massimo Porro
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0570682T3 publication Critical patent/DK0570682T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK93104369.9T 1992-05-07 1993-03-17 Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner DK0570682T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87940392A 1992-05-07 1992-05-07

Publications (1)

Publication Number Publication Date
DK0570682T3 true DK0570682T3 (da) 1998-02-16

Family

ID=25374087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93104369.9T DK0570682T3 (da) 1992-05-07 1993-03-17 Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner

Country Status (14)

Country Link
EP (1) EP0570682B1 (fi)
JP (1) JPH0641200A (fi)
KR (1) KR930023369A (fi)
AT (1) ATE155790T1 (fi)
AU (1) AU664609B2 (fi)
CA (1) CA2095588A1 (fi)
DE (1) DE69312391T2 (fi)
DK (1) DK0570682T3 (fi)
ES (1) ES2104984T3 (fi)
FI (1) FI932053A (fi)
GR (1) GR3024706T3 (fi)
IL (1) IL105605A0 (fi)
NO (1) NO180234C (fi)
SG (1) SG47582A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008214256A (ja) * 2007-03-02 2008-09-18 Yaizu Suisankagaku Industry Co Ltd 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤
WO2010025542A1 (en) * 2008-09-05 2010-03-11 National Research Council Of Canada Lps based vaccines
CN114712383B (zh) * 2016-03-30 2024-09-24 阿尤维斯研究有限公司 新组合物和治疗方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
AU651319B2 (en) * 1989-07-27 1994-07-21 Univax Biologics Incorporated Lipid A analog/immunogenic carrier conjugates and the use thereof as vaccines

Also Published As

Publication number Publication date
KR930023369A (ko) 1993-12-18
AU3841993A (en) 1993-11-11
EP0570682B1 (en) 1997-07-23
EP0570682A1 (en) 1993-11-24
NO931655L (no) 1993-11-08
DE69312391T2 (de) 1997-12-11
SG47582A1 (en) 1998-04-17
CA2095588A1 (en) 1993-11-08
ES2104984T3 (es) 1997-10-16
FI932053A0 (fi) 1993-05-06
NO931655D0 (no) 1993-05-06
GR3024706T3 (en) 1997-12-31
NO180234C (no) 1997-03-12
FI932053A (fi) 1993-11-08
IL105605A0 (en) 1993-09-22
NO180234B (no) 1996-12-02
DE69312391D1 (de) 1997-08-28
JPH0641200A (ja) 1994-02-15
ATE155790T1 (de) 1997-08-15
AU664609B2 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
ES2092306T3 (es) Adyuvante para vacunas.
IT1205820B (it) Adiuvante immunologico per vaccini polisaccaridici
FI931169A0 (fi) Foerbaettrade vaccinkompositioner
FR2598622B1 (fr) Adjuvants immunologiques pour vaccins polysaccharidiques
ZA928162B (en) Antibodies in immunosuppression.
FI862868A0 (fi) Nya aminofenoler och deras anvaendning i oxiderbara haorfaergmedel.
BG94868A (bg) Мутант на бактерията сlоsтrifiuм нisтоlyтiсuм, метод за получаването му и използуването му за производство на свободна от клострипаин колагеназа
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
KR890700832A (ko) 그람 음성균의 항원 결정기와 결합하는 사람 단일클론성 항체
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
NO911262D0 (no) Lettvektsement for anvendelse i omgivelser med hoeyt trykk.
FI923348A0 (fi) Laekemedel och foerfaranden foer kelandering av aids och aids-relaterade komplex (arc) med anvaendning av kolhydratantigener och antikroppar mot kolhydrater.
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
FI911126A0 (fi) Organokupraattimenetelmä kefprotsilin valmistamiseksi
FI913475A (fi) Klass ii protein med immunologiska baerar- och foerstaerkningsegenskaper fraon yttermembranen i neisseria meningitidis och vaccin innehaollande detta.
IT8049346A0 (it) Composizione antigene relativo vaccino e procedimento di produzione
FR2659650B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphnylene diamines.
SE8703453D0 (sv) Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning
IT1130522B (it) Dispositivo per il confezionamento di zolle di colture
SU1672636A1 (ru) Адъювант для производства противоящурной вакцины
ATA29891A (de) Vakzine für eine immuntherapie
IT221500Z2 (it) Dispositivo di presa per cassetti espositori o simili
IT8653055V0 (it) Sistema di schiusura per vetrate pieghevoli senza l ausilio di meccanismi di chiusura tradizionali
DK249690D0 (da) Beholder med laag
IT223982Z2 (it) Borsa per documenti o simili